The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis
- 30 November 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (5), 728-735
- https://doi.org/10.1067/mai.2002.128804
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2002
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthmaAllergy, 2001
- Inflammatory and structural changes in the airways of patients with asthmaRespiratory Medicine, 2000
- The pharmacological basis of anti-IgE therapyNature Biotechnology, 2000
- Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-γ production of T cellsJournal of Allergy and Clinical Immunology, 1999
- Leukotrienes as mediators of airway obstruction and inflammation in asthmaClinical and Experimental Allergy, 1995
- Mediators of allergic rhinitisJournal of Allergy and Clinical Immunology, 1992
- The effect of interleukin 3 upon IgE‐dependent and IgE‐independent basophil degranulation and leukotriene generationEuropean Journal of Immunology, 1991
- IgE receptors on human basophils. Relationship to serum IgE concentration.JCI Insight, 1978